Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metadoxine Extended Release in Adults With ADHD
NCT01243242Phase 2Completed
- Sponsor
- Alcobra Ltd.
- Start
- Feb 2011
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Metadoxine in attention deficit hyperactivity disorder (ADHD), sponsored by Alcobra Ltd.. Started Feb 2011; status: completed.
02
Drugs
Metadoxine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01243242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01243242.